Source: International Congress 2019 – Lung transplantation: from bench to bedside
Disease area: -



Rating:

Share or cite this content

Citations should be made in the following way:
S. M. Lari (Los Angeles, United States of America), M. Shino (Los Angeles, United States of America), A. Derhovanessian (Los Angeles, United States of America), D. Sayah (Los Angeles, United States of America), J. Lynch (Los Angeles, United States of America), R. Saggar (Los Angeles, United States of America), J. Belperio (Los Angeles, United States of America), A. Ardehali (Los Angeles, United States of America), D. Ross (Los Angeles, United States of America), E. Reed (Los Angeles, United States of America), S. Weigt (Los Angeles, United States of America). The impact of pre-transplant donor specific anti-HLA antibodies (DSAs) on lung transplant outcome: A single center experience. 1107

Member's Comments

No comment yet.

Related content which might interest you: Prevalence of pre-transplant anti-HLA antibodies and their impact on outcomes in lung transplant recipients Source: International Congress 2016 – Long-term outcomes of lung transplantation Year: 2016 A virtual crossmatch-based strategy for perioperative desensitisation in lung transplant recipients with pre-formed donor-specific antibodies: 3-year outcome Source: Eur Respir J, 58 (5) 2004090; 10.1183/13993003.04090-2020 Year: 2021 Donor-specific and -nonspecific HLA antibodies and outcome post lung transplantation Source: Eur Respir J, 50 (5) 1701248; 10.1183/13993003.01248-2017 Year: 2017 Pre-transplant soluble CD30 is a stronger predictor of BOS than anti-HLA antibodies occurring after lung transplantation Source: Annual Congress 2007 - New insights into clinical lung transplantation Year: 2007 Role of C1q-binding anti-HLA antibodies as a predictor of lung allograft outcome Source: Eur Respir J, 52 (2) 1701898; 10.1183/13993003.01898-2017 Year: 2018 Impact of donor, recipient and matching on survival after high emergency lung transplantation in France Source: Eur Respir J, 54 (5) 1900096; 10.1183/13993003.00096-2019 Year: 2019 Intragraft donor-specific anti-HLA antibodies in phenotypes of chronic lung allograft dysfunction Source: Eur Respir J, 54 (5) 1900847; 10.1183/13993003.00847-2019 Year: 2019 Longitudinal assessment of CD4+CD25highCD69- treg cells in a cohort of lung transplant recipients (LTR). An association with chronic graft rejection Source: Annual Congress 2008 - Donor organs and complications after lung transplantation Year: 2008 The outcomes of lung transplantation in patients with bronchiectasis and antibody deficiency Source: Eur Respir J 2004; 24: Suppl. 48, 178s Year: 2004 Intragraft donor-specific antibodies and lung transplantation Source: Eur Respir J, 54 (5) 1901937; 10.1183/13993003.01937-2019 Year: 2019 CMV management in lung transplant recipients Source: School Course 2012 - Lung Transplantation Year: 2012 The clinical relevance of mannose-binding lectin (MBL) in long term survival of lung transplant recipients Source: Annual Congress 2010 - Pre-operative evaluation and post-operative problems after lung transplantation Year: 2010 T-cell response against tuberculosis antigens is dependent on the level of immunosuppression in renal and lung transplant patients Source: Eur Respir J 2006; 28: Suppl. 50, 344s Year: 2006 SARS-CoV-2 infection in transplant recipients: experience of a COVID-19 unit in Portugal Source: Virtual Congress 2021 – COVID - 19 around the globe Year: 2021 Specificities of the paediatric lung transplant recipient Source: Annual Congress 2005 - PG9 - Long-term follow-up of lung transplant recipients Year: 2005 Donor and recipient parameters affecting 1-year follow-up after lung transplant: Padova experience Source: Annual Congress 2011 - Lung transplantation Year: 2011 Estimation of quality of life (QoL) of lung transplant recipients by members of the transplant team in comparison with the patients‘ perception Source: Eur Respir J 2006; 28: Suppl. 50, 723s Year: 2006 Fatigue and functional capacity in kidney transplant recipients before and after transplant. Source: International Congress 2017 – Assessing functional outcomes in respiratory physiotherapy Year: 2017 Positive impact of tacrolimus-based immunosuppression after lung transplantation – an analysis of potential risk factors for long-term survival Source: Annual Congress 2007 - New insights into clinical lung transplantation Year: 2007 Pretransplant factors influencing survival in cystic fibrosis (CF) patients after lung transplantation (LTx) Source: Eur Respir J 2006; 28: Suppl. 50, 724s Year: 2006